Market Statistics
| Study Period | 2019 - 2030 |
| 2024 Market Size | 4,299.8 Million |
| 2030 Forecast | 6,916.6 Million |
| Growth Rate (CAGR) | 8.2% |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Nature of the Market | Fragmented |
Clinical Trial Biorepository & Archiving Solutions Market Size
Market Size Comparison
Explore the market potential with our data-driven report
Clinical Trial Biorepository & Archiving Solutions Market Future Prospect
The global clinical trial biorepository & archiving solutions market generated revenue of USD 4299.8 million in 2024, which is projected to exhibit a CAGR of 8.2%, to reach USD 6,916.6 million by 2030. The market advance is attributed to the growing number of firms providing a wide range of services and the burgeoning trend of the outsourcing of storage and other cold-chain operations, so that the critical resources can concentrate more on pharmaceutical development. Moreover, storage and transportation technologies are continuously advancing, which, combined with the l regulatory requirements on bio-storage and the current trends in this space, can immensely help save cost, time, and effort.
Recently, the enormous growth in the demand for stem cell therapy, immunotherapy, and other kinds of regenerative medicines has significantly augmented the demand for low-temperature storage of biological samples. Moreover, many small biopharmaceutical companies do not have an adequate budget, which is why they are shifting toward outsourcing specimen storage and cold-chain logistics. This approach can relieve them of the burden of the high costs of cold-chain management equipment management, equipment and specimen temperature tracking and monitoring, inventory control, and other repository quality management aspects.
Moreover, by outsourcing to biorepositories, biopharmaceutical firms can reduce the biohazards and the delays in regulatory approvals resulting from maintaining and managing large volumes of liquid nitrogen. Moreover, the prevalence of chronic and infectious diseases is increasing, due to which companies are focusing strongly on the discovery and launch of new drugs. Hence, the number of medical trials is increasing; so, companies are availing biorepository & archiving services for the management of the data generated during the whole process.
Moreover, people in different parts of the world have different disease profiles, with those in the larger countries displaying a significant prevalence of more diseases than those in the smaller ones. Therefore, the count of medical studies on novel or rare diseases that, otherwise, might not have attracted sponsors, is growing, which will benefit this market. Moreover, the rising diseased population would encourage pharmaceutical companies to raise their investment in clinical trials of new treatment regimens.
Further, biobanking is seen as an important area by biopharmaceutical companies, as tailored treatments and translation research data are readily available. With the emergence of biobanks, the volume of samples that can be collected and stored for research on companion diagnostics and biomarkers has risen significantly. The growing usage of biomarkers to ascertain and study the underlying causes of diseases is driving the industry growth.
Clinical Trial Biorepository & Archiving Solutions Market Trends & Drivers
The clinical trial biorepository & archiving solutions market is growing rapidly due to the enhancement in the availability of low-cost devices to organize data, for simplifying reporting, utilizing software that offers the functionality of an integrated laboratory information management system designed to help manage laboratory samples and data. Moreover, complex data is created during trials, and the management of such data and all the biorepository processes makes such software necessary, thus creating an opportunity for the providers of archiving solutions.
These systems enable master management, sample lifecycle reporting, stability study, and secure management of the data generated from instruments and during, scheduling, inventory, storage, logistics, and analytical workflow creation. In the coming years, the demand for complete, integrated solutions, to reduce data management errors and enhance the qualitative analysis of research findings, is expected to drive the market growth. Moreover, owing to its advantages, such as inventory tracking without losses, streamlined workflows, efficient sample management, and automated data exchange and reporting, industries are adopting laboratory data management systems widely.
Clinical Trial Biorepository & Archiving Solutions Market Analysis
Stem Cells Held Largest Revenue Share
On the basis of product, stem cells held the largest revenue share, of 40%, in 2023, and this category is further expected to maintain its dominance in the future. Stem cells have drawn a lot of attention because they offer a novel method for cell and gene therapy. It is, thus, important to optimize culturing conditions, cryostorage protocols, and monitoring systems, to obtain ready-to-use cells for clinical applications. Further, in a recent discovery, scientists learned that stem cell therapies can successfully treat heart diseases, thus enhancing the optimism that such regenerative methods may one day be used to cure a variety of difficult-to-treat diseases.
The human tissue category will show the fastest growth during the projection time frame. This will be owing to the rising number of trials and research studies involving the human tissue. The goal of most biomedical research studies is to upgrade the approaches for the treatment and management of diseases. Over the years, the usage of human tissue has increased to develop biologics, to achieve these goals.
Phase III Category Dominates Market
On the basis of phase, the phase III category accounted for the largest revenue share, of 45%, in 2023, and it is further expected to maintain its dominance in the future. This is owing to the fact that phase III trials utilize a large number of specimens and samples for long-term research, which results in a growing demand for clinical trial biorepository and archiving solutions. Researchers and scientists assess the efficacy and safety of novel treatments in phase III of the clinical trial process. In most of the phase III clinical trials, a large patient population is involved for a long duration. In addition to this, this phase has a higher incidence of rare and long-term side-effects, as a large number of people participate over a long time.
The phase II category will show the highest growth rate during the forecast period. After phase III trials, the highest patient participation rate is seen in phase II trials. Moreover, the category is set to grow as a result of the large number of phase II clinical studies that are sponsored or not sponsored by the pharmaceutical sector, their complexity, and their globalization. Essentially, the increasing investment in pharmaceutical and biopharmaceutical R&D is propelling the market growth in this category.
Drive strategic growth with comprehensive market analysis
Geographical Analysis
North America captured the largest revenue share of the market, of around 55%, in 2023, and it is further expected to maintain its dominance during the forecast period. This is due to the growing count of clinical trials, the existence of global market leaders, and the usage of advanced technologies in the region. Moreover, the existence of a large number of service providers, CROs, and biopharmaceutical companies augments the market growth potential.
The U.S. dominates the market in North America due to the growing healthcare expenditure and the existence of a large number of CROs in the country. Moreover, the growing outsourcing of cold-chain management operations and the rising focus on precision medicine propel the market.
Moreover, Canada has made a significant contribution in making North America the dominating regional market with its growing pharmaceutical industry and the dependence of companies on outsourcing. Essentially, the demand for data management tools due to the growing extent of clinical trials is the main market driver.
Moreover, India is undergoing significant growth in the APAC market due to the rising investments in the advancement of the healthcare infrastructure and the robust support of the government for the setup of research laboratories. The Indian government is committed to the creation of 150,000 health and wellness centers.
Market Breakdown
This fully customizable report gives a detailed analysis of the clinical trial biorepository & archiving solutions market, based on all the relevant segments and geographies.
Based on Product
- Human Tissue
- Plasma
- Organs
- Stem Cells
Based on Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Based on Offering
- Biorepository Services
- Archiving Solutions
Geographical Analysis
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- Saudi Arabia
- South Africa
- U.A.E.
Top Clinical Trial Biorepository & Archiving Solutions Companies
- Azenta US Inc.
- Thermo Fisher Scientific Inc.
- Precision Medicine Group LLC
- Medpace Inc.
- Labcorp Drug Development
- American Type Culture Collection
- IQVIA Inc.
- LabConnect Inc.
Frequently Asked Questions About This Report
How big is the clinical trial biorepository & archiving solutions market?+
What is the sales forecast for the clinical trial biorepository & archiving solutions industry?+
Which product leads the clinical trial biorepository & archiving solutions market?+
What is the phase analysis of the clinical trial biorepository & archiving solutions industry?+
Which is the largest clinical trial biorepository & archiving solutions market by region?+
